Patent Assignment
Reel/Frame 021380/0209
Assignment of Assignor's Interest
Recorded: 2008-08-13
Pages: 3
Assignor
SANDOZ GMBH
Executed: 2008-06-18
Assignee
NABRIVA THERAPEUTICS AG
LEBERSTRASSE 20, VIENNA, A-1112, AUSTRIA
Covered Properties
(11)
Cephalosporin Synthesis
Patent:
5,856,474 →
Application:
08/732,501 →
Cephalosporin Compounds
Patent:
6,093,813 →
Application:
09/163,660 →
Cephalosporin Synthesis
Patent:
6,034,237 →
Application:
09/163,942 →
Cephalosporin Synthesis
Patent:
6,063,917 →
Application:
09/164,055 →
Cephalosporines Having Cyclic Aminoguanidine Substituents as Antibiotics
Patent:
6,440,957 →
Application:
09/667,075 →
Antibacterial Cephalosporins
Patent:
6,531,465 →
Application:
09/861,838 →
Antibacterial Substituted 7-Acylamino-3-(Methylhydrazono) Methyl-Cephalosporins and Intermediates
Mutilin Derivatives and Their Use as Antibacterials
Patent:
6,784,193 →
Application:
10/048,438 →
Antibacterial Cephalosporins
Pleuromutilin Derivatives Having Antibacterial Activity
Mutilin Derivatives and Their Use as Antibacterials
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 6, 1998
From: ASCHER, GERD; LUDESCHER, JOHANNES; STURM, HUBERT; WIESER, JOSEF
To: BIOCHEMIE GESELLSCHAFT M.B.H.
Reel/Frame 009300/0437 →
Assignment of Assignor's Interest
Jul 10, 2002
From: ASCHER, GERD; HEILMAYER, WERNER; LUDESCHER, JOHANNES; HILDEBRANDT, JOHANNES
To: BIOCHEMIE GESELLSCHAFT M.B.H.
Reel/Frame 013071/0250 →
Assignment of Assignor's Interest
Nov 7, 2003
From: ASCHER, GERD; WIESER, JOSEF; SCHRANZ, MICHAEL; LUDESCHER, JOHANNES
To: BIOCHEMIE GESELLSCHAFT M.B.H.
Reel/Frame 014674/0400 →
Assignment of Assignor's Interest
May 10, 2004
From: ASCHER, GERD; BERNER, HEINZ
To: SANDOZ GMBH (FORMERLY BIOCHEMIE GMBH)
Reel/Frame 015311/0040 →
Assignment of Assignor's Interest
May 10, 2004
From: ASCHER, GERD; BERNER, HEINZ; HILDEBRANDT, JOHANNES
To: SANDOZ GMBH (FORMERLY BIOCHEMIE GMBH)
Reel/Frame 015311/0007 →
Assignment of Assignor's Interest
Mar 1, 2007
From: ASCHER, GERD; LUDESCHER, JOHANNES
To: BIOCHEMIE GESELLSCHAFT M.B.H.
Reel/Frame 018957/0310 →
Assignment of Assignor's Interest
Mar 1, 2007
From: ASCHER, GERD; BERNER, HEINZ; HILDEBRANDT, JOHANNES
To: BIOCHEMIE GESELLSCHAFT M.B.H.
Reel/Frame 018955/0941 →
Change of Name
Apr 6, 2007
From: BIOCHEMIE GMBH
To: SANDOZ GMBH
Reel/Frame 019130/0814 →
Change of Name
Apr 6, 2007
From: BIOCHEMIE GESELLSCHAFT M.B.H. (AKA BIOCHEMIE GMBH)
To: SANDOZ GMBH
Reel/Frame 019132/0047 →
Change of Name
Apr 11, 2007
From: BIOCHEMIE GESELLSCHAFT M.B.H. (AKA BIOCHEMIE G.M.B.H.)
To: SANDOZ GMBH
Reel/Frame 019147/0784 →
Assignment of Assignor's Interest
Jun 23, 2009
From: ASCHER, GERD; LUDESCHER, JOHANNES; STURM, HUBERT; WIESER, JOSEF
To: BIOCHEMIE GESELLSCHAFT M.B.H.
Reel/Frame 022856/0816 →
Security Interest
Aug 28, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033647/0657 →
Release of Security Interest
Jan 11, 2016
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037455/0436 →
Entity Conversion
Sep 28, 2018
From: NABRIVA THERAPEUTICS AG
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 047160/0234 →
Intellectual Property Security Agreement
Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Security Interest
Jan 18, 2019
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 048062/0807 →
Release of Security Interest
Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest.
Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →